
    
      The drug being tested in this study is called Vonoprazan (Takecab). Vonoprazan is being
      tested to treat people who have gastric or duodenal ulcers.

      This study will look at the safety and efficacy of long-term administration of Vonoprazan
      tablets (Takecab tablets) for up to 12 months in the routine clinical setting in patients
      receiving NSAIDs.

      The study will enroll approximately 1000 patients.

      â€¢ Vonoprazan 10 mg

      This multi-center trial will be conducted in Japan.
    
  